MV
Elite in Metastatic Brain Tumor
Check Dr. Michael A. Vogelbaum's experience treating your condition:
About Dr. Michael A. Vogelbaum

Michael Vogelbaum is a Neurosurgery expert in Tampa, Florida. Vogelbaum has been practicing medicine for over 30 years and is rated as an Elite expert by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Brain Tumor, Metastatic Brain Tumor, Astrocytoma, Glioma, and Gamma Knife Radiosurgery. He is licensed to treat patients in Ohio. Vogelbaum is currently accepting new patients.

His clinical research consists of co-authoring 218 peer reviewed articles and participating in 15 clinical trials in the past 15 years. In particular, he has co-authored 23 articles and participated in 1 clinical trial in the study of Metastatic Brain Tumor.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Michael A. Vogelbaum it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
12902 Usf Magnolia Dr, Tampa, FL 33612
Background & Education
Graduate Institution
University Of Virginia School Of Medicine, 1992
Specialties
Neurosurgery
Licenses
Neurological Surgery in OH
Hospital Affiliations
Moffitt Cancer Center
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


15 Clinical Trials

Phase I/II Study of Stereotactic Radiation and Abemaciclib in the Management of Hormone Receptor Positive HER2 Negative Breast Cancer Brain Metastases
Pre-operative Hypofractionated Stereotactic Radiosurgery for Resectable Brain Metastases
A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma
A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
A Phase 2 Comparative Study of 5-Aminolevulinic Acid (5-ALA) and Intraoperative MRI (iMRI) to Enhance Completeness of Resection of Glioblastoma
Phase I/II Trial of Radiosurgery Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma
Clinical Study of the Utility of a Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
View 10 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Elite
Distinguished